Global Dietary Supplements Market Report 2022: Lifestyle Changes and Demand for Better Nutrition Propel 7.3% Growth – Yahoo Finance

DUBLIN, Sept. 16, 2022 /PRNewswire/ –The “Global Dietary Supplements Market by type (Botanicals, Vitamins, Minerals, Amino Acids, Enzymes, Probiotics), Function (Additional Supplements, Medicinal Supplements, Sports Nutrition), Mode of Application, Target Consumer and Region – Forecast to 2027” report has been added to’s offering.
The market for Dietary Supplements is estimated at USD 155.2 billion in 2022; it is projected to grow at a CAGR of 7.3% to reach USD 220.8 billion by 2027. Increasing consumer health awareness and rising disposable income across regions are factors that have encouraged people to shift to nutraceuticals such as dietary supplements.
Consumers have become increasingly aware and conscious of their dietary habits. Lifestyle changes, along with a better understanding of fitness and health, have encouraged people to consume multivitamins and minerals in the form of capsules and tablets.
Increasing health awareness has also led consumers to shift to customized dietary supplements that are specific to their biological requirements. Consumers have become increasingly inclined toward a healthy lifestyle and additional nutrition. With changing preferences due to increased health awareness, consumers are increasingly seeking dietary supplements in their daily lifestyles.
The Vitamin segment by type is projected to observe the fastest growth in the Dietary Supplements market throughout the forecasted period

In the vitamins segment, popular supplements include vitamin D and vitamin B12. Vitamin D promotes calcium absorption in the gut and maintains adequate serum calcium and phosphate concentrations to enable normal bone mineralization and prevent hypocalcemic tetany. Vitamin B12 is a nutrient that helps keep the body’s nerve and blood cells healthy and helps make DNA (the genetic material in all cells). Over the past couple of years, there has been a rise in concern over the prevention of osteomalacia, which is a vitamin D deficiency disease that causes bone pain and muscle weakness. Such diseases are prevalent in the North American as well as European regions. This has led to a rise in demand for vitamin D dietary supplements in these regions since the consumption of dietary supplements has been on the higher end.

The Additional supplements segment by function is estimated to account for the largest market share in the global Dietary Supplements market

Supplements that can be consumed without the prescription of medical experts fall under this segment. Such dietary supplements can contain minerals, herbs or other botanicals, amino acids, enzymes, and many other ingredients. Dietary supplements come in a variety of forms, including tablets, capsules, gummies, and powders, as well as drinks and energy bars. According to the National Center for Health Statistics, 57.6% of US adults aged 20 and above used a dietary supplement, with women (63.8%) using more than men (50.8%). Multivitamin-mineral supplements were the most commonly used dietary supplements across all age groups, followed by vitamin D and omega-3 fatty acid supplements.

The tablet sub-segment of the by mode of application segment is projected to attain the fastest market growth in Dietary Supplements market over the forecast period

The tablet form is widely consumed and boasts easy availability, affordability, a wide range of dosage patterns, easy packaging, storage, and cost-effectiveness. Tablets also have a high shelf-life and thus find higher preference than other formats of dietary supplements. Tablets are very customizable in terms of size, shape, and colour.

The adults segment by the target consumer is estimated to account for the largest market share in the global Dietary Supplements market

Vitamin deficiency is one of the key factors that have driven the consumption of dietary supplements among adults. According to the US CDC, approximately one-third of US children and adolescents take dietary supplements; use varies by demographic characteristics. Furthermore, the US and Canada have seen rising concerns over the prevention of osteoporotic bone disease, which is caused due to deficiency of calcium. Calcium supplementation and Vitamin D have been recommended to prevent osteoporotic fracture and improve bone health.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Dietary Supplements Market, by Type

8 Dietary Supplements Market, by Function

9 Dietary Supplements Market, by Mode of Application

10 Dietary Supplements Market, by Target Consumer

11 Dietary Supplements Market, by Region

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned
American Health
Amway Corp
Bayer Ag
Bhi Biohealth International GmbH
Biomedical Research Laboratories
Fancl Corporation
Glanbia plc.
GlaxoSmithKline, plc
H&H Group
Herbalife International of America, Inc.
Nature’s Sunshine Products Inc.
Nutrascience Labs
Otsuka Holdings Co., Ltd.
Pfizer Inc
Plantafood Medical GmbH
Pure Encapsulations, LLC.
Ust Corp
For more information about this report visit
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:
SOURCE Research and Markets
Yahoo Finance's Julie Hyman discusses the reversal in Bluebird Bio shares after the FDA approved its second gene therapy.
What happened Shares of Moderna (NASDAQ: MRNA) fell 7% on Monday, following President Joe Biden's interview on 60 Minutes on Sunday.  So what President Biden's comments on the state of the COVID-19 pandemic clearly caught the attention of investors.
It’s been more than 2.5 years and Americans are still suffering from the long-term effects of COVID-19, otherwise known as Long COVID, and it's forced many out of the labor force.
CHMP recommends authorizing AstraZeneca's (AZN) Evusheld as a COVID-19 treatment and its RSV vaccine, nirsevimab in Europe.
The FDA approved Heron Therapeutics Inc's (NASDAQ: HRTX) Aponvie (aprepitant) injectable emulsion for intravenous use for the prevention of postoperative nausea and vomiting (PONV) in adults. Aponvie is the first and only IV formulation of aprepitant for PONV prevention. Aponvie is provided in a single-dose vial that delivers the full 32 mg dose approved for PONV. The ready-to-use, easy-to-administer, innovative IV formulation ensures rapid and consistent exposure in surgery patients. Related: H
Taking dietary supplements may feel like a healthy habit, but experts say certain products may do more harm than good. That's because the U.S. Food and Drug Administration (FDA) regulates supplements as a form of food, not as drugs, so they're subject to far less scrutiny than medication. In fact, oftentimes their touted benefits and possible side effects remain only loosely tested. Ultimately, consumers are left with incomplete information when deciding which supplements to take—if any at all.T
MARKET PULSE Shares of (DK:BAVA) jumped 11% as the drugmaker said it signed a contract amendment with Public Health Canada that’s valued at up to $434 million over ten years. Under the new contract amendment, the majority of the confirmed order for Imvamune will be delivered in 2023, Bavarian Nordic said.
Shares of Moderna fell to the lowest level in roughly three months. Stock in Pfizer and Novavax lost ground as well.
Yet the president warned the U.S. still has “a problem with COVID,” and said the government was “still doing a lotta work on it.”
bluebird's (BLUE) Syskona (eli-cel) gets FDA approval for early, active cerebral adrenoleukodystrophy (CALD) in patients less than 18 years of age.
The CHMP recommends authorizing Sanofi's (SNY) Enjaymo as a treatment for hemolytic anemia in patients with cold agglutinin disease (CAD). The CHMP endorses SNY's RSV vaccine for use in infants.
US Health Sec. Xavier Becerra doubled down on off-the-cuff remarks from President Joe Biden that the pandemic is over in the country.
Intellia Therapeutics (NTLA) reported positive interim results for its CRISPR candidates being evaluated to treat transthyretin (ATTR) amyloidosis and treating hereditary angioedema (HAE).
Photo Illustration by Elizabeth Brockway/The Daily Beast/GettyAll over the world, the rates of death and hospitalization from COVID keep dropping. But our successful mitigation of the worst outcomes of the 33-month-old pandemic belie a growing crisis.More and more people are surviving COVID and staying out of the hospital, but more and more people are also living with long-term symptoms of COVID. Fatigue. Heart problems. Stomach problems. Lung problems. Confusion. Symptoms that can last for mont
Shannon Sharpe says getting tested early may have saved his life.
Two such potential long-term winners are biotechnology companies Krystal Biotech (NASDAQ: KRYS) and BioXcel Therapeutics (NASDAQ: BTAI), and the market could well bid up their stocks over the next 12 months. Biotechs that focus on gene-editing technologies have made a lot of noise in the past few years. Krystal Biotech seeks to develop medicines using gene-editing primarily for dermatologic diseases.
The Department of Social Services takes custody of surrendered newborns. Parents do not face charges if the child is unharmed.
The Queen’s granddaughter has esotropia – a condition that makes people’s eyes look in different directions
By his own admission, Bernd Montag cuts an imposing figure.
Anthony Fauci, the nation’s top infectious disease expert, said in a new interview that the “anti-vaxxer attitude” of some Americans risks causing non-COVID virus outbreaks in the U.S. “I’m concerned the acceleration of an anti-vaxxer attitude in certain segments of the population . . . might spill over into that kind of a negative attitude towards childhood vaccinations,” Fauci…


Leave a Comment